Pharmaceutical package
Today the European Commission adopted a Communication and three legislative proposals with the overarching objective of ensuring that European citizens can increasingly benefit from a competitive industry that generates safe, innovative and accessible medicines.
The third legislative proposal aims at strengthening EU legislation to better protect EU citizens from the serious threats posed by fake medicines. There is an alarming increase of medicinal products detected in the EU which are false representations of authorised medicines. These products usually contain sub-standard or false ingredients, no ingredients or ingredients in the wrong dosage thus posing a serious threat to human health. The overall principle of the proposal adopted today by the European Commission is to protect the legal distribution chain from the infiltration of fake medicines. This will help to ensure confidence of distributors, health care professionals and patients in the medicinal products they trade, prescribe and purchase in the legal supply chain.
Press release, memo, voorstel, meer informatie.
Rechtbank ’s-Gravenhage, ex parte beschikking van 14 november 2008, KG RK 08/1853, Marko Schuhfabrik GmbH tegen Van Woensel B.V.
Rechtbank ’s-Gravenhage, ex parte beschikking van 20 oktober 2008, KG RK 08/1745, Motoport Europe Holding B.V. tegen IGM Trading B.V.
Rechtbank Utrecht, 28 november 2008, KG ZA 08-1100, Hartkamp tegen Basart B.V. & Strengholt B.V. (met dank aan Radboud Ribbert,
GvEA, 10 december 2008, zaak T-290/07, MIP Metro Group Intellectual Property GmbH & Co. KG tegen OHIM / Metronia, SA (Nederlandse vertaling nog niet beschikbaar).
GvEA, 10 december 2008, zaak T-365/06, Compagnie des bateaux mouches SA tegen OHIM / Jean-Noël Castanet (Nederlandse vertaling nog niet beschikbaar).